SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-024224
Filing Date
2023-08-21
Accepted
2023-08-21 08:23:21
Documents
76
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sabs20230630_10q.htm   iXBRL 10-Q 1343271
2 EXHIBIT 31.1 ex_526053.htm EX-31.1 14263
3 EXHIBIT 31.2 ex_526054.htm EX-31.2 14159
4 EXHIBIT 32.1 ex_526055.htm EX-32.1 5424
5 EXHIBIT 32.2 ex_526056.htm EX-32.2 5427
  Complete submission text file 0001437749-23-024224.txt   6793769

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sabs-20230630.xsd EX-101.SCH 66400
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sabs-20230630_cal.xml EX-101.CAL 42105
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sabs-20230630_def.xml EX-101.DEF 442287
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sabs-20230630_lab.xml EX-101.LAB 394461
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sabs-20230630_pre.xml EX-101.PRE 475073
70 EXTRACTED XBRL INSTANCE DOCUMENT sabs20230630_10q_htm.xml XML 994732
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39871 | Film No.: 231187394
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences